Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Stemedica Stock

stemedica.comHealthcareFounded: 2005Funding to Date: $82.12MM

Stemedica Cell Technologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions.

Buy or sell Stemedica stock Learn more about Stemedica IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Stemedica.

Register Today

Team

Management Team

Craig Carlson

Chief Executive Officer

Roger Howe Ph.D

Chairman and Co-Founder

Maynard Howe Ph.D

Co-Founder, Vice Chairman & Chief Executive Officer

Nikolai Tankovich MD

President, Board Member and Chief Medical Officer

Alex Kharazi Ph.D

Chief Technology Officer

Lev Verkh Ph.D

Chief Regulatory and Clinical Development Officer

Board Members

Gary Petrucci

Maynard Howe Ph.D

Nikolai Tankovich MD

Sergey Leshkov

William Maloney MD

Byung-Geon Rhee Ph.D

Green Cross Holdings

Neal Matheson

Richard Mejia Jr.

Simon Guo

Anthony Marlon MD

Guochao Liu

Dirk O'Hara JD

Roger Howe Ph.D

Other companies like Stemedica in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Frequently Asked Questions